Charles V. Biscotti

No ORCID on file · 7 papers in corpus
other 2017
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2016-3527

CONTEXT: Leiomyomas have abundant extracellular matrix (ECM), with upregulation of versican, a large proteoglycan. OBJECTIVE: We investigated ADAMTS (a disintegrin-like and metalloprotease with thrombospondin type 1 motifs) protease-mediat…

case-report 2016
Case reports in pathology ·doi:10.1155/2016/2856358

Establishment of accurate axillary lymph node status is of essential importance in determining both prognosis and the potential need for adjuvant therapy in patients with invasive breast cancer. Axillary lymph node heterotopias can in some …

observational 2013
·doi:10.1093/humrep/det211

Study question: To compare the pregnancy rate in patients submitted to FET (Frozen Embryos Transfer) of cleavage stage embryos (Group 1), or at the blastocyst stage (Group 2). Summary answer: Our data showed that the transfer of frozen blas…

other 2013
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719112466301

BACKGROUND: There is increasing evidence that oxidative stress is one of the key factors for progression of endometriosis. In this prospective controlled trial, we measured 6 different biomarkers of oxidative stress targeting protein, lipid…

other 2010
Diagnostic cytopathology ·doi:10.1002/dc.21246

Endometrium directly sampled from endocervical mucosal endometriosis can mimic endocervical adenocarcinoma in situ (AIS) in Papanicolaou (Pap) tests. We analyzed a series of Pap tests to investigate the cellular features of mucosal endometr…

other 2008
Pathology oncology research : POR ·doi:10.1007/s12253-008-9072-6

Endometriotic foci, especially ovarian ones, with epithelial cytologic atypia may be precursors of cancer. This study presents an overview of the atypical cytological and histopathological findings associated with endometriosis. Six cases o…

other 1989
Gynecologic Oncology ·doi:10.1016/0090-8258(89)90637-9

The clinical and pathologic features of 29 cases of ovarian clear cell adenocarcinoma (OCCA) were studied to evaluate outcome and potential predictors of survival. Patients' ages ranged from 30 to 89 years (median, 54 years). The study grou…